Macular Degeneration Trials
What is Macular Degeneration?
Macular degeneration is an eye disease that causes loss in the center of the field of vision. Dry macular degeneration, the center of the retina deteriorates. With wet macular degeneration, leaky blood vessels grow under the retina.
At University Retina, we have a full-time team dedicated to our clinical trials program and are able to offer our patients the latest drugs and medical devices for treating retinal and macular diseases. If you are interested in learning more or participating in a clinical trial for retinal vein occlusion, please email us using the contact button below.
Director of Clinical Research
Veeral Sheth, MD, FACS
Norse-3 Study A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
A 3-month study to assess the safety of ophthalmic bevacizumab (ONS-5010) in subjects with visual impairment diagnosed with a retinal condition that would benefit from treatment with intravitreal injection of bevacizumab due to retinal disorders: exudative age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion.
Sponsor: Outlook Therapeutics, Inc.
Read about the study on clinicaltrials.gov, here.